I agree that this site is using cookies. You can find further informations here.
X
Magen Rimon, R
94  results:
Search for persons X
?
1

P467 5-ASA is not superior to no-maintenance in patients wi..:

Atia, O ; Goren, I ; Sharar Fischler, T...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i596-i596 , 2023
Link: https://doi.org/10.1093/..
 
?
2

P458 Safety and Potential Efficacy of Escalating Dose of Us..:

Yerushalmy-Feler, A ; Pujol-Muncunill, G ; Martin-de-Carpi, J...
Journal of Crohn's and Colitis.  16 (2022)  Supplement_1 - p. i435-i435 , 2022
Link: https://doi.org/10.1093/..
 
?
3

DOP39 Utilization and sustainability of biologics in UC - A..:

Atia, O ; Yogev, D ; Friss, C...
Journal of Crohn's and Colitis.  15 (2021)  Supplement_1 - p. S077-S078 , 2021
Link: https://doi.org/10.1093/..
 
?
4

DOP44 Long term outcomes of patients with untreated IBD - A..:

Magen Rimon, R ; Atia, O ; Friss, C...
Journal of Crohn's and Colitis.  15 (2021)  Supplement_1 - p. S081-S082 , 2021
Link: https://doi.org/10.1093/..
 
?
5

DOP45 Utilization and sustainability of biologics in CD - A..:

Atia, O ; Yogev, D ; Chagit, F...
Journal of Crohn's and Colitis.  15 (2021)  Supplement_1 - p. S082-S083 , 2021
Link: https://doi.org/10.1093/..
 
?
6

P1156 Characteristics and outcomes of over a million Inflam..:

Weisshof, R ; Magen-Rimon, R ; Voss, E...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i2066-i2066 , 2024
Link: https://doi.org/10.1093/..
 
?
7

P553 The safety and efficacy of adalimumab 80mg weekly as m..:

Cohen-Sela, E ; Weintraub, Y ; Yerushalmy-Feler, A...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1088-i1088 , 2024
Link: https://doi.org/10.1093/..
 
?
8

Durability of Adalimumab and Infliximab in Children With Cr..:

Atia, Ohad ; Friss, Chagit ; Focht, Gili...
Inflammatory Bowel Diseases.  , 2024
Link: https://doi.org/10.1093/..
 
?
9

Durability of the First Biologic in Children and Adults Wit..:

Atia, Ohad ; Friss, Chagit ; Focht, Gili...
Inflammatory Bowel Diseases.  , 2024
Link: https://doi.org/10.1093/..
 
?
10

Prevalence and Outcomes of No Treatment Versus 5-ASA in Ulc..:

Atia, Ohad ; Magen Rimon, Ramit ; Ledderman, Natan...
Inflammatory Bowel Diseases.  , 2023
Link: https://doi.org/10.1093/..
 
?
11

Durability of the First Biologic in Patients with Crohn's D..:

Atia, Ohad ; Friss, Chagit ; Focht, Gili...
Journal of Crohn's and Colitis.  18 (2023)  1 - p. 38-46 , 2023
Link: https://doi.org/10.1093/..
 
?
12

Three-year follow-up of patients with panic disorder after ..:

Lepola, U. M. ; Rimón, R. H. ; Riekkinen, P. J.
International Clinical Psychopharmacology.  8 (1993)  2 - p. 115-118 , 1993
Link: https://doi.org/10.1097/..
 
?
13

Physical Disease, Hypochondria, and Alcohol Addiction in Su..:

Stenback, Asser ; Achté, K. A. ; Rimón, R. H.
British Journal of Psychiatry.  111 (1965)  479 - p. 933-937 , 1965
Link: https://doi.org/10.1192/..
 
?
14

REM sleep and prolactin in patients with non-affective psyc..:

Appelberg, B. ; Katila, H. ; Rimón, R.
Schizophrenia Research.  41 (2000)  1 - p. 150 , 2000
Link: https://doi.org/10.1016/..
 
?
15

Olanzapine and perphanazine in schizophrenia:

Naukkarinen, H. ; Rimón, R. ; Katila, H...
Schizophrenia Research.  41 (2000)  1 - p. 190 , 2000
Link: https://doi.org/10.1016/..
 
1-15